1. Home
  2. GRNQ vs ALLR Comparison

GRNQ vs ALLR Comparison

Compare GRNQ & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • ALLR
  • Stock Information
  • Founded
  • GRNQ 2013
  • ALLR 2004
  • Country
  • GRNQ Malaysia
  • ALLR United States
  • Employees
  • GRNQ N/A
  • ALLR N/A
  • Industry
  • GRNQ EDP Services
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • ALLR Health Care
  • Exchange
  • GRNQ Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • GRNQ 13.3M
  • ALLR 13.3M
  • IPO Year
  • GRNQ 2018
  • ALLR N/A
  • Fundamental
  • Price
  • GRNQ $1.54
  • ALLR $1.00
  • Analyst Decision
  • GRNQ
  • ALLR
  • Analyst Count
  • GRNQ 0
  • ALLR 0
  • Target Price
  • GRNQ N/A
  • ALLR N/A
  • AVG Volume (30 Days)
  • GRNQ 85.5K
  • ALLR 464.0K
  • Earning Date
  • GRNQ 08-12-2025
  • ALLR 08-04-2025
  • Dividend Yield
  • GRNQ N/A
  • ALLR N/A
  • EPS Growth
  • GRNQ N/A
  • ALLR N/A
  • EPS
  • GRNQ N/A
  • ALLR N/A
  • Revenue
  • GRNQ $3,190,761.00
  • ALLR N/A
  • Revenue This Year
  • GRNQ N/A
  • ALLR N/A
  • Revenue Next Year
  • GRNQ N/A
  • ALLR N/A
  • P/E Ratio
  • GRNQ N/A
  • ALLR N/A
  • Revenue Growth
  • GRNQ N/A
  • ALLR N/A
  • 52 Week Low
  • GRNQ $0.80
  • ALLR $0.61
  • 52 Week High
  • GRNQ $2.24
  • ALLR $7.45
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 56.94
  • ALLR 54.51
  • Support Level
  • GRNQ $1.47
  • ALLR $0.80
  • Resistance Level
  • GRNQ $1.70
  • ALLR $1.09
  • Average True Range (ATR)
  • GRNQ 0.18
  • ALLR 0.07
  • MACD
  • GRNQ -0.01
  • ALLR 0.02
  • Stochastic Oscillator
  • GRNQ 48.19
  • ALLR 63.03

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: